Contrast agent for photoacoustic imaging
US-2015290345-A1 · Oct 15, 2015 · US
US10842889B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10842889-B2 |
| Application number | US-201615171746-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jun 2, 2016 |
| Priority date | Jun 2, 2015 |
| Publication date | Nov 24, 2020 |
| Grant date | Nov 24, 2020 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
A contrast composition for photoacoustic imaging includes a photoacoustic contrast agent and a gelling agent.
Opening claim text (preview).
What is claimed is: 1. A method of photoacoustic imaging, the method comprising: administering a contrast composition for photoacoustic imaging comprising a photoacoustic contrast agent and a gelling agent to a site of a subject, wherein the photoacoustic contrast agent is charcoal and wherein the gelling agent is pectin or amylo pectin; between one and four weeks after administering the contrast composition including charcoal, and pectin or amylo pectin, irradiating light to the site of the subject where the contrast composition for photoacoustic imaging is administered to cause the administered charcoal to generate acoustic waves; and when the light is irradiated between one and four weeks after administering the contrast composition including charcoal, and pectin or amylo pectin, detecting the acoustic waves in a range of 1 MHz to 40 MHz generated by the administered charcoal to form an image. 2. The method of claim 1 , wherein an amount of the photoacoustic contrast agent comprised in the contrast composition is in a range of about 0.5 (w/v) % to about 15 (w/v) %. 3. The method of claim 1 , wherein an amount of the gelling agent comprised in the contrast composition is in a range of about 0.5 (w/v) % to about 15 (w/v) %. 4. The method of claim 1 , wherein a wavelength of the irradiated light is in a range of about 500 nm to 1,300 nm. 5. The method of claim 1 , wherein a viscosity of the gelling agent is about 50 cP to 300 cP. 6. The method of claim 1 , wherein the site of the subject is at least one of a region where a lesion is present, an abdominal cavity, a heart, a gastrointestinal tract, a pancreas, a gall bladder, a spleen, lymph nodes, a liver, a kidney, or an eye. 7. The method of claim 1 , wherein the contrast composition is administered in tissue or blood vessels of the subject. 8. The method of claim 1 , the contrast composition having higher durability in the site of the subject compared to a contrast composition comprising charcoal alone.
Solutes, emulsions, suspensions, dispersions, semi-solid forms, e.g. hydrogels · CPC title
for contrast media · CPC title
by applying light and detecting acoustic waves, i.e. photoacoustic measurements · CPC title
Echographic preparations; Ultrasonic imaging preparations · CPC title
for the heart · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.